Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding

Charlotte Mérie; Lars Køber; Peter Skov Olsen; Charlotte Andersson; Gunnar Gislason; Jan Skov Jensen; Christian Torp-Pedersen

doi:10.1001/jama.2012.54506

Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding

Charlotte Mérie
, Lars Køber
, Peter Skov Olsen
, Charlotte Andersson
, Gunnar Gislason
, Jan Skov Jensen
, Christian Torp-Pedersen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.

Originalsprog	Engelsk
Tidsskrift	J A M A: The Journal of the American Medical Association
Vol/bind	308
Udgave nummer	20
Sider (fra-til)	2118-25
Antal sider	8
ISSN	0098-7484
DOI	https://doi.org/10.1001/jama.2012.54506
Status	Udgivet - 2012

Adgang til dokumentet

10.1001/jama.2012.54506

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

Mérie, C., Køber, L., Skov Olsen, P., Andersson, C., Gislason, G., Skov Jensen, J., & Torp-Pedersen, C. (2012). Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. J A M A: The Journal of the American Medical Association, 308(20), 2118-25. https://doi.org/10.1001/jama.2012.54506

Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. / Mérie, Charlotte; Køber, Lars; Skov Olsen, Peter et al.
I: J A M A: The Journal of the American Medical Association, Bind 308, Nr. 20, 2012, s. 2118-25.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Mérie, C, Køber, L, Skov Olsen, P, Andersson, C, Gislason, G, Skov Jensen, J & Torp-Pedersen, C 2012, 'Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding', J A M A: The Journal of the American Medical Association, bind 308, nr. 20, s. 2118-25. https://doi.org/10.1001/jama.2012.54506

@article{5bd5a6836e7b4a71b70ea97f6ba71fe5,

title = "Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding",

abstract = "The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.",

author = "Charlotte M{\'e}rie and Lars K{\o}ber and \{Skov Olsen\}, Peter and Charlotte Andersson and Gunnar Gislason and \{Skov Jensen\}, Jan and Christian Torp-Pedersen",

year = "2012",

doi = "10.1001/jama.2012.54506",

language = "English",

volume = "308",

pages = "2118--25",

journal = "J A M A: The Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "20",

}

TY - JOUR

T1 - Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding

AU - Mérie, Charlotte

AU - Køber, Lars

AU - Skov Olsen, Peter

AU - Andersson, Charlotte

AU - Gislason, Gunnar

AU - Skov Jensen, Jan

AU - Torp-Pedersen, Christian

PY - 2012

Y1 - 2012

N2 - The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.

AB - The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.

U2 - 10.1001/jama.2012.54506

DO - 10.1001/jama.2012.54506

M3 - Journal article

C2 - 23188028

SN - 0098-7484

VL - 308

SP - 2118

EP - 2125

JO - J A M A: The Journal of the American Medical Association

JF - J A M A: The Journal of the American Medical Association

IS - 20

ER -